Pharmaceutical Product Development, LLC Expanding Bioanalytical Laboratory In Richmond

Pixabay License | Source:  Ulrike Leone , no changes made.
Advertisement

Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ increasing research needs.

Founded in 1985, headquartered in Wilmington, North Carolina, PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. PPD has labs in Richmond; Middleton, Wisconsin; Highland Heights, Kentucky; Athlone, Ireland; Brussels, Belgium; Shanghai, China; and Singapore.

The company’s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 22,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

Advertisement The Springer Shop

The expansion of the lab’s immunochemistry, biomarker and chromatography services builds on PPD’s ongoing investments in its Richmond facilities, which also have included significant previous enhancements to its vaccine sciences, biomarker, genomics and automation services. The current expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet, which will be used for both biomarker lab capacity and a dedicated lab team for one of PPD’s global biopharmaceutical clients.

Additionally, this month the company plans to begin the process of adding 30,000 square feet of space dedicated to chromatography services. This step will enable PPD to design and build a state-of-the-art facility focusing on modern mass spectrometry and automation and offering a layout optimized for the bioanalysis of complex molecules, such as antibody-drug conjugates, and advanced biotherapeutics, such as cell and gene therapies. Work also is scheduled to begin this month to create a 4,500-square-foot cell lab. This summer, PPD completed the move of administrative staff into 36,000 square feet at One Holland Place. And, earlier this year the company completed an 8,600-square-foot expansion to its sample management and biorepository offerings.

“The ongoing expansion of our bioanalytical lab – coupled with previous enhancements to our biologics capabilities – builds on the growth of our drug development expertise over the past three decades to the point that we now support pharmaceutical programs from preclinical through post-approval.” … “These additions – which we are thankful Virginia and Henrico County officials have welcomed and supported – will enable us to more effectively and efficiently respond to the growing needs of our customers as they seek to deliver more life-changing therapies. We’re confident these enhancements will enable us to continue our record of success with our customers.” – Christopher Fikry, M.D., executive vice president, PPD® Laboratories

Sources

  1. https://www.businesswire.com/news/home/20190919005472/en/PPD-Expanding-Bioanalytical-Laboratory-Capabilities
  2. https://www.crunchbase.com/organization/ppd#section-overview
Advertisement

David is a consultant/medical writer for a number of ongoing healthcare initiatives including for Athla LLC/ HealthLabs, a discovery automation company for Big Data leveraging Big Compute. He has a number of years experience in academic R&D and healthcare related projects including the fields of oncology and immunotherapy.